Building category-defining healthcare companies at the inflection point of growth.
Totipotent Capital backs early growth-stage healthcare and life sciences companies with demonstrated traction, investing just before meaningful scale. Our portfolio reflects a disciplined, thesis-driven approach informed by deep clinical, operational, and regulatory expertise.
Selected Portfolio
Select
All
Fund I
Fund II
Antiverse
Antiverse
Fund I
Live Site
Fuse Oncology
Fuse Oncology
Fund I
Live Site
Agile Devices
Agile Devices
Fund I
Live Site
Joylux
Joylux
Fund I
Live Site
Peptinovo Biopharma
Peptinovo Biopharma
Fund I
Live Site
Elitone
Elitone
Fund I
Live Site
Smileyscope
Smileyscope
Fund I
Live Site
Wavely Diagnostics
Wavely Diagnostics
Fund I
Live Site
Wellsheet
Wellsheet
Fund I
Live Site
Midstream Health
Midstream Health
Fund I
Live Site
Embr Labs
Embr Labs
Fund I
Live Site
Biorithm
Biorithm
Fund I
Live Site
What We Look For
Demonstrated Traction
Commercial validation through customer adoption, revenue growth, clinical outcomes, or strategic partnerships.
Clear Path to Scale
Businesses positioned for repeatable growth through scalable execution, operational leverage, and disciplined economics.
Healthcare System Alignment
Solutions designed to integrate within clinical workflows, reimbursement models, regulatory frameworks, and evolving models of care.
Differentiated Advantage
Technology, data, or market positioning that creates durable competitive advantage and long-term strategic value.
Exceptional Teams
Founders with deep domain expertise, operational discipline, and the ability to navigate complex healthcare environments.
Inflection Point Opportunity
Companies entering a stage where traction, timing, and operational readiness converge to accelerate growth and reduce risk.